Cyclin E plays a pivotal role in the regulation of G(1)-S transition and re
lates to malignant transformation of cells. However, the clinical significa
nce of cyclin E in patients with laryngeal squamous cell carcinoma (LSCC) r
emains unknown. We examined the expression of cyclin E in 102 patients with
LSCC and analyzed its relation to clinicopathological parameters, cell pro
liferation, and clinical outcome. Cyclin E overexpression was observed in 5
4 cases (52.94%) of LSCC and was significantly correlated with the tumor si
te (P = 0.012), tumor size (P = 0.006), poor differentiation (P = 0.026), l
ymph node metastasis (P = 0.012), and advanced stage (P = 0.002), A positiv
e correlation between the cyclin E expression and proliferative activity of
tumor cells was Pound (r = 0.896; P < 0.0001), Kaplan-Meier analysis showe
d that shorter disease-free and overall survival was significantly associat
ed with proliferating cell nuclear antigen (PCNA) overexpression and cyclin
E overexpression, When PCNA and cyclin E are combined, the patients with b
oth PCNA overexpression and cyclin E overexpression had the poorest prognos
es when compared with the other cases. Additionally, in early stage (I-II)
cases, cyclin E was also revealed to possess a significant prognostic role.
By multivariate analysis, lymph node metastasis and cyclin E overexpressio
n were independent prognostic factors for disease-free survival, and tumor
size, lymph node metastasis, advanced stage, as well as cyclin E overexpres
sion were independent prognostic factors for overall survival. These findin
gs indicate that cyclin E overexpression is associated with unfavorable cli
nicopathological parameters and represents an independent marker for cell p
roliferation and prognosis of LSCC.